NCT07814937

Brief Summary

Ankle fractures are among the most common fractures in trauma care, with an estimated annual incidence of 100 to 150 per 100,000 inhabitants and a marked increase after age 40. These fractures affect both young individuals-typically following high-energy trauma-and older adults-often resulting from low-energy falls-with a female predominance in the latter group. Surgical fixation (for bi-malleolar, tri-malleolar, or unstable fractures) remains the gold standard for displaced or unstable injuries, requiring appropriate anesthetic management. Ankle surgery is recognized as one of the most painful orthopedic procedures in the postoperative period, due to extensive local innervation and significant tissue edema. Despite advances in multimodal analgesia protocols-incorporating paracetamol, nefopam, non-steroidal anti-inflammatory drugs (NSAIDs), and corticosteroids-postoperative pain remains inadequately controlled in a significant proportion of patients. Persistent pain after discharge is associated with a twofold increase in the risk of emergency department visits or hospital readmission, highlighting the clinical and socioeconomic impact of insufficient postoperative analgesia. Furthermore, postoperative pain following ankle surgery is not limited to a nociceptive component. Intraoperative nerve injuries (such as traction neuropraxia or compression caused by edema or fixation hardware) can induce a neuropathic component, which is frequently underestimated in clinical practice.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
260

participants targeted

Target at P75+ for all trials

Timeline
19mo left

Started Oct 2026

Geographic Reach
1 country

4 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Oct 2026May 2028

First Submitted

Initial submission to the registry

September 1, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 11, 2026

Completed
20 days until next milestone

Study Start

First participant enrolled

October 1, 2026

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 3, 2028

Last Updated

September 11, 2026

Status Verified

September 1, 2026

Enrollment Period

1.1 years

First QC Date

September 1, 2026

Last Update Submit

September 10, 2026

Conditions

Keywords

the quality of postoperative recovery

Outcome Measures

Primary Outcomes (1)

  • To compare recovery quality on postoperative days 5-7, measured by the global QoR-15F score, between patients undergoing surgery under truncal regional anesthesia and those undergoing surgery under spinal anesthesia.

    Calculation of the global QoR-15F score on postoperative days 5-7 (range: 0-150), comparing the truncal regional anesthesia group with the spinal anesthesia group. The QoR-15F consists of 15 questions, each rated on a scale of 0 to 10. (0 = very poor state / severe symptom and 10 = best possible state). The total score is therefore obtained by summing the 15 responses : QoR-15F score = Q1 + Q2 + Q3 + … + Q15. (150 → optimal recovery; high score → good quality of recovery; low score → more difficult recovery, with more symptoms or limitations).

    between 5 and 7 days

Secondary Outcomes (4)

  • Describe and compare the QoR-15F score at days 5-7 across three groups: truncal block, spinal anesthesia, and genOverall QoR-15F score at days 5-7 across the three groups (truncal block, spinal anesthesia, general anesthesia), and analysis of sub-scores.

    between 5 and 7 days

  • Compare pain at days 5-7 between groups (NRS 0-10 at rest and during mobilization, proportion of NRS > 3)

    between 5 and 7 days

  • Assessment of the neuropathic component of pain at days 5-7 (DN4i score, proportion of DN4i ≥ 3).

    between 5 and 7 days

  • Compare analgesic consumption between Day 0 and Days 5-7 (non-opioid and opioid analgesics)

    7 days

Interventions

Assessment of patient recovery following ankle surgery and anesthesia by collecting clinical monitoring data intraoperatively, and postoperatively estimates of pain, the neuropathic component of pain, analgesic consumption, and satisfaction with medical care.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patient requiring ankle surgery (unimalleolar, bimalleolar, or trimalleolar fracture; osteosynthesis; tibiotalar or subtalar arthrodesis, etc.)

You may qualify if:

  • Age ≥ 18 years.
  • Ankle surgery (uni-, bi-, or trimalleolar fracture; osteosynthesis; tibiotalar or subtalar arthrodesis, etc.).
  • Elective or emergency surgery.
  • Anesthesia via nerve block, spinal anesthesia, or general anesthesia.
  • Ability to understand French and answer a questionnaire by telephone.
  • Patient informed and having expressed no objection to the research (non-objection).

You may not qualify if:

  • Under 18 years of age.
  • Inability to perform central or peripheral regional anesthesia due to acquired or congenital hemostasis disorders, use of antiplatelet agents, or other contraindications to regional anesthesia.
  • Surgery not involving the ankle or foot. Pure local anesthesia administered by the surgeon without an anesthesiologist.
  • Major cognitive impairment or inability to respond (language barrier, severe uncorrected deafness, etc.).
  • Patient under legal guardianship, curatorship, judicial protection, or deprived of liberty.
  • Explicit refusal to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Department of Anesthesiology and Intensive Care

Dieppe, 76200, France

Location

Department of Anesthesiology and Intensive Care

Elbeuf, 76231, France

Location

Department of Anesthesiology and Intensive Care

Le Havre, 76600, France

Location

Department of Anesthesiology and Intensive Care

Rouen, 76031, France

Location

Study Officials

  • Arthur AW WILDEMERSCH, Doctor

    University Rouen Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nabila NL LAAJAIL, Director

CONTACT

Vincent VF FERRANTI, ARC

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 1, 2026

First Posted

September 11, 2026

Study Start

October 1, 2026

Primary Completion (Estimated)

November 1, 2027

Study Completion (Estimated)

May 3, 2028

Last Updated

September 11, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Locations